Evaluation of an ultrasmall superparamagnetic iron oxide in MRI in a bone tumor model in rabbits
| Autor: | Christopher R.J. Mladinich, William J. Montgomery, Charles H. Bush |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Pathology
medicine.medical_specialty Iron Contrast Media Bone Neoplasms Sensitivity and Specificity Animals Medicine Radiology Nuclear Medicine and imaging Tumor growth Magnetite Nanoparticles business.industry Ultrasmall superparamagnetic iron oxide Soft tissue Dextrans Oxides Mononuclear phagocyte system Image Enhancement Magnetic Resonance Imaging Ferrosoferric Oxide Disease Models Animal medicine.anatomical_structure Evaluation Studies as Topic Dynamic contrast-enhanced MRI Rabbits Lymph Bone marrow Signal intensity business |
| Zdroj: | Journal of Magnetic Resonance Imaging. 7:579-584 |
| ISSN: | 1522-2586 1053-1807 |
| DOI: | 10.1002/jmri.1880070320 |
| Popis: | Ultrasmall superparamagnetic iron oxides (USPIOs) are a class of MRI contrast agents having moderately selective affinity for the reticuloendothelial cells of lymph nodes and bone marrow. This study evaluated a USPIO preparation, Combidex (Code 7227), in MRI of a rabbit bone tumor model. VX2 carcinoma implanted into the tibial marrow of nine subject rabbits was studied. After tumor growth, the subjects underwent MRI of their lesions both before and after intravenous administration of Code 7227. Code 7227 was judged subjectively to conspicuously reduce the signal intensity of normal marrow on some pulse sequences. A hypointense zone outlined the tumor margins on postcontrast imaging, which allowed improved visualization of the soft tissue component of the larger lesions. Accumulation of the contrast agent in a zone of inflammation outside the tumor margin was demonstrated on histologic sections of the lesions. Code 7227 deserves additional study as a potential contrast agent for MRI of bone tumors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text